Featured

All drug manufacturers responsible for manufacturing the 10 prescription medicines that will be subject to the inaugural price negotiations for the U.S. Medicare health programme, such as Amgen as well as Novartis, have confirmed their participation in the talks by the...

The European Federation of Pharmaceutical Industries and Associations (EFPIA) recently warned that more than 600 essential medicines could be at risk if suggested limitations on the use of fluorinated substances, especially per- and polyfluoroalkyl substances- PFAS, in pharmaceutical manufacturing...

The proposal by the European Commission to re-examine the pharmaceutical legislation has ignited an extensive debate. The suggestion in the directive to offer Member States the option to choose among electronic as well as traditional paper medical leaflets builds upon valid worries when it comes to potentially eliminating...

In recent years, there has been an increasing awareness of the importance when it comes to acting quickly and also being adaptable when it comes to the development and delivery of pharmaceutical products. The expedited trials for the COVID-19...

A paper published in the IEEE Sensors Journal has gone on to showcase an apt method for effectively verifying the content of pharmaceutical packaging with an accuracy rate that happens to be 100% that has been made possible by...

The global pharmaceutical industry has found itself under the intense glare of public scrutiny, and this scrutiny has been fueled by a multitude of factors. These factors encompass a wide range of concerns, from the cyclical and uneven availability...

With the emergence of the cell and gene therapy industry, a new set of supply chain challenges has come to the forefront. Biopharmaceutical companies find themselves in the position of needing to optimize their distribution networks and supporting infrastructure...